NCT03564769

Evaluation Study of SPOTme® Skin Cancer Screenings

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 431 (actual)
• Sponsor: Harvard School of Public Health (HSPH) · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.

Detailed description

Despite tremendous growth in both the interest and volume of skin cancer screenings at the national level, the actual utility and impact of the AAD SPOT me™ skin cancer screening programs have not been fully evaluated. This study will address this knowledge gap. Early detection is vital in the fight against skin cancer, the most common cancer in the United States. While the effects of skin cancer can be devastating, this disease is highly treatable when detected early. This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.

Conditions

• Skin Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Intervention Arm	Individuals randomized to the intervention group will receive skin cancer screening educational materials.
OTHER	AAD SPOTmeⓇ skin cancer screening	All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.

Timeline

• Start date: 2017-12-01
• Primary completion: 2018-10-01
• Completion: 2019-06-01
• First posted: 2018-06-21
• Last updated: 2019-08-13

Locations

1 site across 1 country: United States